Volume | 392,664 |
|
|||||
News | - | ||||||
Day High | 7.825 | Low High |
|||||
Day Low | 7.5253 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Outlook Therapeutics Inc | OTLK | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
7.75 | 7.5253 | 7.825 | 7.58 | 7.73 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4,974 | 392,664 | $ 7.64 | $ 2,999,682 | - | 4.004 - 40.60 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:52:02 | 9 | $ 7.60 | USD |
Outlook Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
98.51M | 13.01M | - | 0 | -58.98M | -4.53 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Outlook Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLK Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 8.57 | 8.91 | 7.5253 | 8.13 | 243,882 | -0.73 | -8.52% |
1 Month | 9.03 | 9.2899 | 7.5253 | 8.38 | 226,363 | -1.19 | -13.18% |
3 Months | 9.566 | 12.8499 | 5.0401 | 8.44 | 1,159,007 | -1.73 | -18.04% |
6 Months | 8.90 | 12.8499 | 5.0401 | 8.54 | 1,633,485 | -1.06 | -11.91% |
1 Year | 23.40 | 40.60 | 4.004 | 10.67 | 4,057,918 | -15.56 | -66.50% |
3 Years | 42.80 | 65.40 | 4.004 | 20.04 | 2,124,350 | -34.96 | -81.68% |
5 Years | 25.00 | 85.20 | 4.004 | 26.54 | 2,134,978 | -17.16 | -68.64% |
Outlook Therapeutics Description
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. |